Adalimumab Biosimilar Market Growth Drivers

добавлена новая статья Health

2026-06-26 09:32:33 -

Multiple factors propel the Adalimumab Biosimilar Market forward. Rising prevalence of autoimmune diseases affects approximately 5% of the global population, creating sustained demand for affordable treatment options. The WHO reports increasing cases of rheumatoid arthritis and Crohn's disease, with incidence rising 30% over the past decade. Cost-effectiveness remains a primary driver, as...

0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр